Try GOLD - Free
Fresh from Middle East victory, Trump sets his sights on peace in Ukraine
Mint Mumbai
|October 15, 2025
Pressure on Hamas worked for Gaza, but Trump has yet to fully ramp up pressure on Russia

Trump will host Ukrainian President Volodymyr Zelensky at the White House on Friday.
(AP)
resident Trump scored a major foreign-policy win in Gaza by brokering the release of hostages from captivity and securing an end to the fighting between Israel and Hamas.
Now Europeans are hoping Trump can repeat the success with another knotty foreign-policy problem.
Trump will host Ukrainian President Volodymyr Zelensky at the White House on Friday, according to officials familiar with the plans, on the heels of his diplomatic victory tour in the Middle East. At his stops in Israel and Egypt, Trump referenced the continuing war between Russia and Ukraine, underscoring how, as he touted his achievements on one major conflict, he has still set his sights on resolving another.
The two wars are vastly different. In the 2022 Russian invasion and Oct. 7, 2023 terrorist attacks, respectively, Ukraine and Israel both faced unprovoked attacks that triggered the wars. But in the Middle East, Israel proved itself to be the dominant regional military force, while in Europe, it is Russia that remains a major global power with a sizable nuclear arsenal.
Senior U.S. and European officials caution that neither Russia nor Ukraine will change their war strategies over Trump’s initial success in the Middle East. They also point out that a longer-term deal to bring lasting peace to Gaza is far from certain.
But they still hope the U.S. president can seize on the momentum of the diplomatic victory—and draw the right lessons to revive efforts to bring Russian President Vladimir Putin back to the negotiating table.
“This gives Trump enormous leverage to solve other major conflicts,” said Fred Fleitz, who was a senior National Security Council official during the first term. “He’s now proven himself as an effective arbiter and peacemaker.”
This story is from the October 15, 2025 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
JSW Steel eyes strong H2 on demand, policy boost
After reporting robust numbers for the second quarter despite a challenging global environment, JSW Steel said it expects a strong second half for the company on the back of 8-9% growth in domestic demand for steel in FY26.
2 mins
October 18, 2025
Mint Mumbai
Govt plans Golden Quadrilateral 2.0 to expand road grid
The Union government is planning a sequel to the Golden Quadrilateral network of national highways, introducing high-speed expressways linking India's major economic centres, according to two officials aware of the matter.
2 mins
October 18, 2025

Mint Mumbai
RIL Q2: Profit surges 16% as all engines gain steam
All of its key businesses—O2C, telecom and retail—saw marginal improvements
3 mins
October 18, 2025
Mint Mumbai
Gift with intention
Communication isn't just about exchanging information; it's about exchanging information that makes us understand, comprehend and feel for one another.
1 mins
October 18, 2025

Mint Mumbai
Food delivery growth cushions Blinkit losses for Eternal in Q2
Eternal Ltd (formerly known as Zomato) posted amixed bag performance in the September quarter (Q2FY26).
2 mins
October 18, 2025

Mint Mumbai
In the dark about light pollution
Beset as we are with many kinds of pollution, we barely pay attention to light pollution and ignore the risks it poses
5 mins
October 18, 2025

Mint Mumbai
12 states, UTs support e-bus payment plan
PM E-bus Sewa PSM scheme plans to build confidence in e-bus makers
2 mins
October 18, 2025
Mint Mumbai
Govt plans highway network to expand road grid
The officials did not disclose the planned length of the proposed high-speed expressways or the investment.
1 min
October 18, 2025
Mint Mumbai
SC allows Natco to sell generic of Roche drug until case ends
The Supreme Court on Friday rejected Swiss pharmaceutical giant F. Hoffmann-La Roche AG's (Roche) pleaseeking that Natco Pharma Ltd berestricted from selling the generic version of its lifesaving spinal muscular atrophy (SMA) drug, Risdiplam, in India until the conclusion of the case.
2 mins
October 18, 2025

Mint Mumbai
Dixon meets revenue goal in Q2, bets on components
Topline grows 33% on year to ₹14,855 cr, unsold goods from Q1 drive profits in Sep quarter
3 mins
October 18, 2025
Listen
Translate
Change font size